Global health and food security constantly face the challenge of emerging human and plant
diseases caused by bacteria, viruses, fungi, and other pathogens. Disease outbreaks such …

Massive viral outbreaks draw attention to viruses that have not been thoroughly studied or
understood. In recent decades, microfluidic chips, known as “lab-on-a-chip”, appears as a …

Rapid, efficient and accurate nucleic acid molecule detection is important in the screening of
diseases and pathogens, yet remains a limiting factor at point of care (POC) treatment …

Recent severe acute respiratory syndrome 2 (SARS-CoV-2) known as COVID-19, presents a
deadly challenge to the global healthcare system of developing and developed countries …

The dengue virus (DENV) is a vector-borne flavivirus that infects around 390 million
individuals each year with 2.5 billion being in danger. Having access to testing is paramount …

Abstract Point-Of-Care (POC) testing has advanced to more affordable and rapid
alternatives by adapting conventional immunoassays and molecular assays (isothermal …

Digital PCR (polymerase chain reaction) is a powerful and attractive tool for the
quantification of nucleic acids. However, the multiplex detection capabilities of this system …

Whole genome amplification (WGA) is a technology for non‐selective amplification of the
whole genome sequence, first appearing in 1992. Its primary purpose is to amplify and …

Nucleic acid (NA) extraction is a basic step for genetic analysis, from scientific research to
diagnostic and forensic applications. It aims at preparing samples for its application with …

The gold standard for diagnosing infectious diseases is culture-based identification of
bacterial pathogens, which is time-consuming and labour-intensive. Current advances in …